← Back to Search

Scarcity Narrative for Alcoholism (RP1B Trial)

N/A
Waitlist Available
Led By Stephen M LaConte, PhD
Research Sponsored by Virginia Polytechnic Institute and State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
21 years of age or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at the first session (s1; baseline measures) and session 2 (s2; occurs approximately 2-3 days after s1)
Awards & highlights

RP1B Trial Summary

This trial aims to investigate how economic scarcity impacts alcohol use disorder. Previous studies have shown that scarcity, which refers to a lack of money and resources, can lead to neglecting the future and higher rates

Who is the study for?
This trial is for adults over 21 who drink heavily (AUDIT>15) and want to reduce their drinking but aren't planning on getting treatment during the study. They must also prefer a type of alcohol that fits the study's testing.Check my eligibility
What is being tested?
The trial tests how 'scarcity narrative' versus 'neutral narrative' affects attention, cognitive function, and desire for alcohol in heavy drinkers. It looks at whether making people focus on immediate needs changes how they value and crave alcohol.See study design
What are the potential side effects?
Since this trial involves psychological interventions rather than medications, traditional side effects are not expected. However, participants may experience stress or discomfort when discussing personal financial scarcity or alcohol use.

RP1B Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 21 years old or older.

RP1B Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at the first session (s1; baseline measures) and session 2 (s2; occurs approximately 2-3 days after s1)
This trial's timeline: 3 weeks for screening, Varies for treatment, and at the first session (s1; baseline measures) and session 2 (s2; occurs approximately 2-3 days after s1) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Ethanol
Ethanol
Change in Delay Discounting
Secondary outcome measures
Change in Positive and Negative Affect Schedule
Change in Stress Appraisal Measure

RP1B Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Scarcity NarrativeExperimental Treatment1 Intervention
Participants assigned to the scarcity group will be asked to listen and consider a hypothetical narrative about a sudden loss of resources.
Group II: Neutral NarrativePlacebo Group1 Intervention
Participants assigned to the neutral group will be asked to listen and consider a hypothetical narrative about a neutral change in resources.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Scarcity Narrative
2018
N/A
~80

Find a Location

Who is running the clinical trial?

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
801 Previous Clinical Trials
1,365,285 Total Patients Enrolled
423 Trials studying Alcoholism
985,596 Patients Enrolled for Alcoholism
University of KentuckyOTHER
186 Previous Clinical Trials
226,572 Total Patients Enrolled
2 Trials studying Alcoholism
160 Patients Enrolled for Alcoholism
Virginia Polytechnic Institute and State UniversityLead Sponsor
142 Previous Clinical Trials
27,645 Total Patients Enrolled
6 Trials studying Alcoholism
1,108 Patients Enrolled for Alcoholism

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for eligible individuals to participate in this ongoing research study?

"As stated on clinicaltrials.gov, this specific medical trial is not currently accepting new participants. It was initially posted on September 21st, 2023 and last updated on January 11th, 2024. However, it's worth noting that there are presently a total of 377 other active clinical trials actively enrolling patients at the moment."

Answered by AI
~25 spots leftby Jun 2024